MedPath

Neurophysiologic Correlates of Hypersomnia

Completed
Conditions
Bipolar Disorder
Narcolepsy
Major Depressive Disorder
Primary Insomnia
Primary Hypersomnia
Registration Number
NCT01719315
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

The goal of this project is to examine the neurophysiology of hypersomnia during sleep and wakefulness, to identify biomarkers for excessive sleepiness in neuropsychiatric disorders, and pilot acoustical slow wave induction during sleep in patients with hypersomnolence, to determine if this decreases daytime sleepiness in these patients. The primary study hypotheses are that individuals with hypersomnolence will have reduced slow wave activity (SWA) during sleep and increased waking theta/alpha activity during wake in specific brain regions. A secondary hypothesis is that acoustical slow wave induction in hypersomnolent patients will increase SWA during sleep, reduce theta/alpha activity during wake, and improve subjective sleepiness.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
76
Inclusion Criteria
  • Meet Diagnostic and Statistical Manual edition IV criteria for neuropsychiatric disorders enumerated in study population description
Exclusion Criteria

Exclusionary criteria for all subjects will include: evidence of a clinically significant sleep disorder that would cause hypersomnolence (e.g. moderate to severe obstructive sleep apnea, restless legs syndrome, shift-work sleep disorder), history of significant head trauma or loss of consciousness > 30 minutes; current smoking of more than 15 cigarettes per day; >3 caffeinated beverages per day; significant neurologic or medical illness; active drug/alcohol abuse/dependence (within 6 months of enrollment), women who are pregnant, <6 months post-partum, nursing or planning to become pregnant during the study; left-handedness (due to effects on sleep topography); and imminent risk for self-harm or suicide.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Nocturnal Slow Wave ActivityIndividual nights of sleep recorded within an average of 4 weeks of enrollment

EEG recordings during sleep will be analyzed to assess slow wave activity in the 1-4.5Hz range.

Secondary Outcome Measures
NameTimeMethod
Waking theta/alpha activityIndividual days of waking EEG will be recorded within an average of 4 weeks of enrollment

Waking EEG activity across the 1-12Hz range will be analyzed.

Trial Locations

Locations (1)

University of Wisconsin-Madison, Department of Psychiatry

🇺🇸

Madison, Wisconsin, United States

University of Wisconsin-Madison, Department of Psychiatry
🇺🇸Madison, Wisconsin, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.